Today: 21 May 2026
CBA shares stop falling — but the next CPI print could jolt Commonwealth Bank stock
8 January 2026
1 min read

CBA shares stop falling — but the next CPI print could jolt Commonwealth Bank stock

Sydney, Jan 8, 2026, 16:50 AEDT — Market closed

Commonwealth Bank of Australia (ASX: CBA) closed up a fraction on Thursday, ending 0.03% higher at A$153.27 after swinging between A$152.45 and A$153.76. Turnover was about 1.0 million shares, after a 1.68% drop in the prior session.

Why it matters now: CBA is a rates stock in a market that can’t settle on rates. A softer November inflation read cooled the immediate panic, but it did not kill the chance of another Reserve Bank of Australia move, and investors keep pushing the timing around.

On Thursday, RBA Deputy Governor Andrew Hauser said the inflation slowdown was “helpful” but broadly expected, and warned policymakers still see the level as too high. “Inflation above 3% — let’s be clear, it’s too high,” he said, according to an ABC interview. Reuters

The bank sector has already started repricing. On Wednesday, interest-rate swaps — derivatives that reflect where traders think the cash rate is heading — implied about a 35% chance of a quarter-point hike next month, and CBA slid 1.7% to a near four-week low as other big banks also fell. Greg Boland, a market strategy consultant at Moomoo Australia, said “odds of a hold or even modest hikes” now outweighed fresh cuts in the near term. The Economic Times

CBA trades on a rich multiple by local bank standards, leaving less room for surprises to go the right way. The stock’s 52-week range is A$140.21 to A$192.00, and it changes hands at about 25 times trailing earnings, Investing.com data show.

With the market shut, the next company marker is already circled: CBA is due to report half-year results and announce an interim dividend on Feb. 11, with the interim dividend set to go ex-dividend on Feb. 18, the bank’s financial calendar shows. Investors will watch the net interest margin, bad-debt trends and any hints on mortgage competition.

But the bigger near-term risk for the whole bank tape is macro. The ABS will publish December and December-quarter CPI on Jan. 28 at 11:30 a.m. AEDT, and a hot print would likely lift hike odds again — bad news for valuations and sentiment, even if higher rates can help margins.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI
Previous Story

Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI

CapitaLand Investment stock climbs after S$260 million Singapore automated logistics bet
Next Story

CapitaLand Investment stock climbs after S$260 million Singapore automated logistics bet

Go toTop